{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT05011474",
      "OrgStudyIdInfo": {
        "OrgStudyId": "2018-10-013"
      },
      "Organization": {
        "OrgFullName": "CHA University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration",
      "OfficialTitle": "Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration",
      "Acronym": "MANT3_ASC"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2021",
      "OverallStatus": "Enrolling by invitation",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 23, 2021",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "January 20, 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 31, 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "August 17, 2021",
      "StudyFirstSubmitQCDate": "August 17, 2021",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 18, 2021",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "August 19, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 25, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor-Investigator",
        "ResponsiblePartyInvestigatorFullName": "Inbo Han",
        "ResponsiblePartyInvestigatorTitle": "Professor, Spine Neurosurgeon, Bundang CHA Hospital",
        "ResponsiblePartyInvestigatorAffiliation": "CHA University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Inbo Han",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "To investigate the safety and efficacy of autologous adipose-derived mesenchymal stem cell spheroids pretreated with matrillin-3 in chronic low back pain patients with lumbar intervertebral disc degeneration."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Patients With Chronic Low Back Pain Due to Degenerative Lumbar Disc"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignInterventionModelDescription": "This clinical trial is a Phase 1/2a, open and researcher-led clinical trial. Subjects will be enrolled in succession, signed informed consent, and administered an autologous adipose-derived mesenchymal stem cell spheroid pretreated with matrillin 3 to each eligible subject meeting all selection criteria.",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "4",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "administered an autologous adipose-derived mesenchymal stem cell spheroid pretreated with matrillin 3",
            "InterventionDescription": "Adipose-derived mesenchymal stem cells isolated from subject's adipose tissue are pretreated with matrillin 3 and produced in spheroid form."
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "1) Adverse reaction and serious adverse reaction evaluation 2) laboratory inspection 3) Vital signs 4) Biochemical examination 5) Lumbar MRI 6) Monitoring systemic infection",
            "PrimaryOutcomeDescription": "It will be considered safe and tolerated in the absence of the following:\n\nGrade 3 (NCI grading system) or higher adverse reactions related to cell products\nAny evidence that the cells are contaminated with infectious substances\nAny evidence that cells show tumorigenic potential",
            "PrimaryOutcomeTimeFrame": "During Clinical Trial Period"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Confirmation of the degree of pain improvement in VAS",
            "SecondaryOutcomeDescription": "on a scale of 0 to 10, with 0 meaning no pain and 10 meaning the worst pain you can imagine",
            "SecondaryOutcomeTimeFrame": "before and at 1 week, 1, 3, 6 months after stem cell injection"
          },
          {
            "SecondaryOutcomeMeasure": "Confirmation of the degree of improvement in disability (ODI)",
            "SecondaryOutcomeDescription": "on a scale of 0 to 3, with 0 meaning no disability and 10 meaning severe disability",
            "SecondaryOutcomeTimeFrame": "before stem cell injection and at 1 week, 1, 3, and 6 months after injection"
          },
          {
            "SecondaryOutcomeMeasure": "Confirmation of increase in water content in the nucleus using MRI",
            "SecondaryOutcomeTimeFrame": "before stem cell injection and at 1 and 6 month after injection"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMale and female patients aged 19-70 years\nAmong the subjects with low back pain, conventional conservative treatment is performed, but the back pain or hip pain persists for more than 3 months, and it is determined that the cause of the back pain is a degenerative disc (MRI checks for a degenerative disc)\nHas Oswestry Disability score(ODI) ≥ 30%\nHas Visual Analogue Scale(VAS) ≥ 4\nBetween lumbar 1-sacral 1, Magnetic Resonance Imaging (MRI) grade according to the Pfirrmann classification is 3~4.\nHas one or two degenerative lumbar discs identified by MRI (Confirmation of low back pain due to disc through various nerve block procedures.)\nConsent was prepared for stem cell administration\n\nExclusion Criteria:\n\nPatient requiring surgery due to severe pain in lower extremities due to severe nerve compression due to severe lumbar stenosis or prolapse of lumbar nucleus.\npatient with spinal instability, spondylitis, or vertebral fracture\ntype 3 Modic change is in an endplate\nPatient whose disc height has decreased by more than 1/2 due to severe disc degenerative change\nPatient with severe osteoporosis (The average value of the T score in the lumbar spine bone density test is -2.5 or less)\nhas undergone surgery, such as disc resection, on the disc to which the cells will be administered\nPatient who received lumbar epidural steroid injection 3 weeks before cell administration\nPregnant or lactating women\n\nAmong female patients who are likely to become pregnant during the clinical trial, who do not use medically acceptable methods of contraception\n\nmedically acceptable methods of contraception: condom, Oral contraception lasting for at least 3 months, Has received an infusion pill before 3 months, using an injectable or implantable contraceptive, or installed an intrauterine contraceptive device\nhas a history of psychiatry or who are currently undergoing treatment, who judged that it is difficult to proceed with the clinical trial under the judgment of the researcher\nPatient with drug or alcohol addiction who cannot understand the purpose and method of this clinical trial\nPatient who participated in other clinical trials within 3 months prior to participation in the trial\nPatient who may affect this clinical trial due to serious medical conditions (hypertension not controlled by drugs, diabetes not controlled by drugs, cirrhosis, kidney failure, tumors)\nPatient with a history of malignant tumors within the last 5 years\nhas a history of administration of cell therapy products\nOther persons who have clinically significant findings deemed inappropriate for this clinical trial due to medical judgment by the person in charge of the clinical trial",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "19 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "CHA University, CHA Bundang Medical Center",
            "LocationCity": "Seongnam-si",
            "LocationState": "Gyeonggi-do",
            "LocationCountry": "Korea, Republic of"
          }
        ]
      }
    },
    "ReferencesModule": {
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Related Info",
            "SeeAlsoLinkURL": "https://sites.google.com/view/inbolab/home"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000055959",
            "ConditionMeshTerm": "Intervertebral Disc Degeneration"
          },
          {
            "ConditionMeshId": "D000001416",
            "ConditionMeshTerm": "Back Pain"
          },
          {
            "ConditionMeshId": "D000017116",
            "ConditionMeshTerm": "Low Back Pain"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010146",
            "ConditionAncestorTerm": "Pain"
          },
          {
            "ConditionAncestorId": "D000009461",
            "ConditionAncestorTerm": "Neurologic Manifestations"
          },
          {
            "ConditionAncestorId": "D000013122",
            "ConditionAncestorTerm": "Spinal Diseases"
          },
          {
            "ConditionAncestorId": "D000001847",
            "ConditionAncestorTerm": "Bone Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M3866",
            "ConditionBrowseLeafName": "Back Pain",
            "ConditionBrowseLeafAsFound": "Back Pain",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18585",
            "ConditionBrowseLeafName": "Low Back Pain",
            "ConditionBrowseLeafAsFound": "Low Back Pain",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M27558",
            "ConditionBrowseLeafName": "Intervertebral Disc Degeneration",
            "ConditionBrowseLeafAsFound": "Intervertebral Disc Degeneration",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M12218",
            "ConditionBrowseLeafName": "Pain",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11556",
            "ConditionBrowseLeafName": "Neurologic Manifestations",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M15071",
            "ConditionBrowseLeafName": "Spinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4278",
            "ConditionBrowseLeafName": "Bone Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          }
        ]
      }
    }
  }
}